Trial Profile
Treatment of Asian Flushing Syndrome With Topical Alpha Agonists
Status:
Completed
Phase of Trial:
Phase 0
Latest Information Update: 04 Nov 2021
Price :
$35
*
At a glance
- Drugs Brimonidine (Primary)
- Indications Erythema; Flushing
- Focus Therapeutic Use
- 04 Dec 2019 Primary endpoint (Patient Erythema Self Assessment) has been met, according to the results published in the JAMA Dermatology.
- 04 Dec 2019 Primary endpoint (Clinician Erythema Score) has been met, according to the results published in the JAMA Dermatology.
- 04 Dec 2019 Results (n=20) published in the JAMA Dermatology.